21ST CENTURY THERAPEUTICS, INC. in Shelby Township, Michigan
Web Results:
- 21st Century Therapeutics, Inc. Publictions
- HOME | ABOUT | COLLABORATORS/CONTRACTORS | PUBLICATIONS | NEWS | CONTACT | 21-CTI WEBMAIL Publications Jiajiu Shaw, Ben Chen, Paul Wooley, Wen-Hsin Huang, An-Rong Lee and Dustin Zeng. Anti-inflammatory and Anti-arthritic Effects of a Novel Leflunomide Analogue, UTL-5b (GBL-5b). Am J Biomed Sci, 2011...
- COLLABORATORS/CONTRACTORS
- HOME | ABOUT | COLLABORATORS/CONTRACTORS | PUBLICATIONS | NEWS | CONTACT | 21-CTI WEBMAIL Collaborators and Contractors GeneBlue Corporation Licensing and collaboration agreements to develop potential agents for rheumatoid arthritis and adjuvant therapeutic agents for treating cancer Henry Ford Heal...
- 21st Century Therapeutics, Inc. About
- HOME | ABOUT | COLLABORATORS/CONTRACTORS | PUBLICATIONS | NEWS | CONTACT | 21-CTI WEBMAIL About 21st Century Therapeutics Dr. Frederick Valeriote, CEO Dr. Valeriote began his academic career as an Assistant Professor in the Department of Radiology at Washington University in St. Louis as Director of...
- 21st Century Therapeutics, Inc. Contact
- HOME | ABOUT | COLLABORATORS/CONTRACTORS | PUBLICATIONS | NEWS | CONTACT | 21-CTI WEBMAIL 21st Century Therapeutics Contact Address 1366 Hilton Rd. Ferndale, MI Email info@21-cti.com Phone (248) 545-0595 2011 21st Century Therapeutics, Inc. All Rights Reserved. ...
- 21st Century Therapeutics, Inc. Home
- HOME | ABOUT | COLLABORATORS/CONTRACTORS | PUBLICATIONS | NEWS | CONTACT | 21-CTI WEBMAIL 21st Century Therapeutics (21 CTI) Chemoprotector UTL-5g is a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor under development as a chemoprotetive agent. This project has received an SBIR Phase I ...
Business Information:
In Business Since: | 2002 |
Business Sector: | Residential, Commercial |